GE invests in ultrasound therapy

Article

No sooner did GE complete one investment than it made another, albeit smaller, one. GE Medical Systems has taken an equity stake in InSightec, a subsidiary of Elbit Medical

No sooner did GE complete one investment than it made another, albeit smaller, one. GE Medical Systems has taken an equity stake in InSightec, a subsidiary of Elbit Medical Imaging. InSightec is developing an MRI-guided, high-intensity, focused ultrasound system as a possible replacement for some surgical procedures. Per the agreement, GEMS will invest $10 million in a combination of cash and equipment for 11.8% of InSightec's shares. GEMS will also convert its previous 5% holdings in InSightec into an additional 5% holding and receive warrants for the purchase of another 5% of InSightec shares for $3 million, exercisable for a period of three years.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.